| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK). | Cancer Biol Ther | 2010 | 1.49 |
| 2 | How can we improve antibody-based cancer therapy? | MAbs | 2010 | 0.80 |
| 3 | The rational design of a novel potent analogue of the 5'-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity. | Bioorg Med Chem Lett | 2010 | 0.78 |